Yi Zhi Hui, Ouyang Qin, Li Gan Di, Chen Dai Yun
Department of Gastroenterology, West China Hospital, Sichuan Universty, Chengdu, Sichuan Province, China.
Chin J Dig Dis. 2006;7(1):12-8. doi: 10.1111/j.1443-9573.2006.00238.x.
To establish a sequential diagnostic procedure of gastric mucosa-associated lymphoid tissue (MALT) lymphoma and provide evidence for selected optimal cases to be treated in the early stage.
Thirty-one cases of gastric lymphoid hyperplasia (GLH) were selected and multiple investigations including histology, protein level, DNA and chromosome levels, combined with clinical follow-up were performed. Histological grade was according to Isaacson's criteria of GLH; CD20, UCHL-1 (CD45RO), anti-kappa (kappa), anti-lambda (lambda) and Ki-67 were used for immunohistochemical staining; semi-nested polymerase chain reaction (PCR) was used to detect IgH gene rearrangement and reverse-transcription PCR (RT-PCR) was used to detect API2-MALT1 fusion of the chromosome translocation t(11;18)(q21;q21). Twenty-nine cases underwent eradication therapy for Helicobacter pylori. Changes in histological grade, endoscopic appearance, expression of Ki-67 and IgH gene rearrangement were compared after eradication treatment.
Of the 31 cases of GLH with predominant chronic gastritis and gastric ulcer most were histological grade 2 and 3. Only one case had lambda light chain restriction and 10 cases had monoclonal IgH gene rearrangement. Expression of Ki-67 and monoclonal IgH gene rearrangement were significantly increased with increased lymphoid hyperplasia (P < 0.05). Two cases had API2-MALT1 fusion. Helicobacter pylori was eradicated in 25 cases and another course of treatment had to be given in 4 cases. All cases were followed up for 1.5-37 months. Of the 27 successful eradication cases, 18 showed complete regression both histologically and endoscopically, 4 had partial regression and 7 were unchanged.
A sequential diagnostic procedure based on histology, expression of Ki-67 combined with clonality of IgH rearrangement and API2-MALT1 fusion helps to diagnosis of early stage gastric MALT lymphoma and choose the best treatment strategy.
建立胃黏膜相关淋巴组织(MALT)淋巴瘤的序贯诊断程序,并为选择早期治疗的最佳病例提供依据。
选取31例胃淋巴组织增生(GLH)病例,进行包括组织学、蛋白质水平、DNA和染色体水平在内的多项检查,并结合临床随访。组织学分级依据Isaacson的GLH标准;采用CD20、UCHL-1(CD45RO)、抗κ(kappa)、抗λ(lambda)和Ki-67进行免疫组织化学染色;采用半巢式聚合酶链反应(PCR)检测IgH基因重排,采用逆转录PCR(RT-PCR)检测染色体易位t(11;18)(q21;q21)的API2-MALT1融合。29例患者接受了幽门螺杆菌根除治疗。比较根除治疗后组织学分级、内镜表现、Ki-67表达及IgH基因重排的变化。
31例以慢性胃炎和胃溃疡为主的GLH病例中,多数为组织学2级和3级。仅1例有λ轻链限制,10例有单克隆IgH基因重排。Ki-67表达和单克隆IgH基因重排随淋巴组织增生增加而显著升高(P<0.05)。2例有API2-MALT1融合。25例幽门螺杆菌被根除,4例需再次治疗。所有病例随访1.5~37个月。27例成功根除病例中,18例组织学和内镜均完全缓解,4例部分缓解,7例无变化。
基于组织学、Ki-67表达结合IgH重排的克隆性及API2-MALT1融合的序贯诊断程序有助于早期胃MALT淋巴瘤的诊断及选择最佳治疗策略。